Mesenchymal stromal cell delivery as a potential therapeutic strategy against COVID-19: Promising evidence from in vitro results

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic, which was initiated in December 2019. COVID-19 is characterized by a low mortality rate (< 6%); however, this percentage is higher in elderly people and pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallis, Panagiotis, Chatzistamatiou, Theofanis, Dimou, Zetta, Sarri, Eirini-Faidra, Georgiou, Eleni, Salagianni, Maria, Triantafyllia, Vasiliki, Andreakos, Evangelos, Stavropoulos-Giokas, Catherine, Michalopoulos, Efstathios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966500/
https://www.ncbi.nlm.nih.gov/pubmed/35432769
http://dx.doi.org/10.4331/wjbc.v13.i2.47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966500/
https://www.ncbi.nlm.nih.gov/pubmed/35432769
http://dx.doi.org/10.4331/wjbc.v13.i2.47

Ejemplares similares